Moreover, our data indicated that the hypermethylated CEACAM5 group showed molecular pathological features with a BRAF mutation, TGFB2 mutation, MSI‐H, and proximally located colon tumors that were similar to CMS1 tumors. The gene discussed is BRAF; the disease is colonic neoplasm.